International Lab Verification: Blue Eyes Biotech Hydrolyzed Casein Meets Superior Standards for Pharmaceutical & Nutraceutical Raw Materials

Article Title: International Lab Verification: Blue Eyes Biotech Hydrolyzed Casein Meets Superior Standards for Pharmaceutical & Nutraceutical Raw Materials

Page Description: This report, issued by an independent international testing agency, provides a detailed analysis of the chemical composition, purity, and compliance of Blue Eyes Biotech Hydrolyzed Casein. Data confirms its high protein content, controlled molecular weight distribution, and conformity with USP/EP/FCC standards, making it an ideal choice for pharmaceutical and nutritional product manufacturers.

Body:

This document is issued by an independent international analytical laboratory accredited to ISO 17025 standards, aiming to comprehensively

evaluate the quality parameters of Hydrolyzed Casein produced by Blue Eyes Biotech CO., Ltd. The testing was conducted in strict

accordance with relevant guidelines from the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Food Chemicals

Codex (FCC), providing objective, data-driven evidence for procurement decisions in the global pharmaceutical, high-end nutraceutical, and

functional food industries.

Core composition analysis shows that the crude protein content (on a dry basis) of Blue Eyes Biotech Hydrolyzed Casein exceeds 90%,

confirming its fundamental value as a highly efficient protein source. In-depth analysis via High-Performance Liquid Chromatography (HPLC)

and Gel Permeation Chromatography (GPC) further reveals that the product features a carefully controlled peptide molecular weight

distribution. A significant proportion consists of peptides with a molecular weight below 5000 Daltons, a characteristic crucial for ensuring

excellent solubility, stability, and ease of absorption in final formulations. This controlled hydrolysis process is a direct reflection of Blue Eyes

Biotech's technical expertise.

Regarding critical safety and compliance indicators, this Hydrolyzed Casein also performs excellently. Heavy metal (lead, arsenic, cadmium,

mercury) content test results are well below the limits set by major global regulations. Microbial limit tests, including total aerobic microbial

count, yeast, mold, and specific pathogens like E. coli and Salmonella, all meet stringent requirements for pharmaceutical and food

ingredients. Furthermore, physicochemical indicators such as moisture and ash content are fully within specified ranges, ensuring the raw

material's stability during storage and processing.

Synthesizing all test data, Blue Eyes Biotech Hydrolyzed Casein not only meets basic high-purity requirements but also demonstrates quality

exceeding ordinary food-grade ingredients in terms of fine peptide profile control and safety standards. This enables it to seamlessly

integrate into various high-end application scenarios, from pharmaceutical excipients and enteral nutrition formulations to high-protein

sports nutrition products, providing downstream manufacturers with a core raw material solution that combines reliability and innovation

potential.

For the complete Certificate of Analysis (CoA) for this batch of Hydrolyzed Casein or for technical consultation, please contact:

Company:Blue Eyes Biotech CO., Ltd

Email:[email protected]

Website:www.blueeyes-bio.com

WhatsApp:+66840769830

Keywords: Hydrolyzed Casein testing, High protein content, Peptide molecular weight distribution, USP/EP/FCC compliance,

Pharmaceutical-grade raw material, Nutraceutical ingredient, International quality standards, Composition analysis, Blue Eyes Biotech

Facebook Tags:

#HydrolyzedCasein#ProteinRawMaterial #USP #PharmaceuticalGrade #NutraceuticalIngredient #QualityTesting #Peptides #BlueEyesBiotech